Sartorius Stedim Biotech S.A.
OTC: SDMHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- René Fáber
- Employees
- 10,009
- Headquarters
- Aubagne, France
- IPO year
- 2009
- Market cap
- $18.6B
- Website
- https://www.sartorius.com
Loading SDMHF…
Loading profile data…Frequently asked questions about SDMHF
What does Sartorius Stedim Biotech S.A. (SDMHF) do?
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as...
Where does SDMHF trade?
Sartorius Stedim Biotech S.A. (SDMHF) trades on the Other OTC.
What sector is SDMHF in?
Sartorius Stedim Biotech S.A. (SDMHF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Sartorius Stedim Biotech S.A.?
René Fáber is the chief executive officer of Sartorius Stedim Biotech S.A. (SDMHF).
Where is Sartorius Stedim Biotech S.A. headquartered?
Sartorius Stedim Biotech S.A. is headquartered in France.
Does SDMHF pay a dividend?
Yes — Sartorius Stedim Biotech S.A. (SDMHF) paid a trailing twelve-month dividend of USD 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SDMHF go public?
Sartorius Stedim Biotech S.A. (SDMHF) completed its initial public offering in 2009.